Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 8;13:5145–5153. doi: 10.2147/OTT.S244853

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Yang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

miR-203a inhibitor promotes proliferation in lung cancer cells. (A) miR-203a inhibitor or inhibitor-ctrl was transfection in A549/H1299 cells and determined by CCK-8 assay. (B) Colony formation was performed to detect the effect on A549/H1299 cells treated with miR-203a inhibitor or inhibitor-ctrl (*P<0.05, **P<0.01). (C) Apoptosis was detected in A549/H1299 cells after transfection with miR-203a inhibitor or inhibitor-ctrl (*P<0.05, **P<0.01). (D) BIRC5 protein expression levels were measured in A549/H1299 cells after transfection with miR-203a inhibitor or inhibitor-ctrl by Western blot (*P<0.05, **P<0.01).